chr12-6044493-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000552.5(VWF):​c.2282-42C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.542 in 1,601,648 control chromosomes in the GnomAD database, including 240,752 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.49 ( 20148 hom., cov: 32)
Exomes 𝑓: 0.55 ( 220604 hom. )

Consequence

VWF
NM_000552.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.420

Publications

22 publications found
Variant links:
Genes affected
VWF (HGNC:12726): (von Willebrand factor) This gene encodes a glycoprotein involved in hemostasis. The encoded preproprotein is proteolytically processed following assembly into large multimeric complexes. These complexes function in the adhesion of platelets to sites of vascular injury and the transport of various proteins in the blood. Mutations in this gene result in von Willebrand disease, an inherited bleeding disorder. An unprocessed pseudogene has been found on chromosome 22. [provided by RefSeq, Oct 2015]
VWF Gene-Disease associations (from GenCC):
  • hereditary von Willebrand disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • von Willebrand disease type 2B
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • von Willebrand disease 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • von Willebrand disease 1
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • von Willebrand disease type 2A
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease type 2M
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease 3
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease type 2N
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 12-6044493-G-T is Benign according to our data. Variant chr12-6044493-G-T is described in ClinVar as Benign. ClinVar VariationId is 256658.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.685 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VWFNM_000552.5 linkc.2282-42C>A intron_variant Intron 17 of 51 ENST00000261405.10 NP_000543.3
VWFXM_047429501.1 linkc.2282-42C>A intron_variant Intron 17 of 51 XP_047285457.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VWFENST00000261405.10 linkc.2282-42C>A intron_variant Intron 17 of 51 1 NM_000552.5 ENSP00000261405.5
VWFENST00000538635.5 linkn.421-50559C>A intron_variant Intron 5 of 5 4

Frequencies

GnomAD3 genomes
AF:
0.493
AC:
74953
AN:
151954
Hom.:
20135
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.283
Gnomad AMI
AF:
0.540
Gnomad AMR
AF:
0.645
Gnomad ASJ
AF:
0.643
Gnomad EAS
AF:
0.703
Gnomad SAS
AF:
0.654
Gnomad FIN
AF:
0.537
Gnomad MID
AF:
0.677
Gnomad NFE
AF:
0.543
Gnomad OTH
AF:
0.539
GnomAD2 exomes
AF:
0.585
AC:
135035
AN:
230794
AF XY:
0.586
show subpopulations
Gnomad AFR exome
AF:
0.278
Gnomad AMR exome
AF:
0.740
Gnomad ASJ exome
AF:
0.648
Gnomad EAS exome
AF:
0.722
Gnomad FIN exome
AF:
0.533
Gnomad NFE exome
AF:
0.545
Gnomad OTH exome
AF:
0.590
GnomAD4 exome
AF:
0.547
AC:
793387
AN:
1449576
Hom.:
220604
Cov.:
35
AF XY:
0.550
AC XY:
396376
AN XY:
720474
show subpopulations
African (AFR)
AF:
0.276
AC:
9149
AN:
33188
American (AMR)
AF:
0.723
AC:
31229
AN:
43174
Ashkenazi Jewish (ASJ)
AF:
0.649
AC:
16836
AN:
25932
East Asian (EAS)
AF:
0.699
AC:
27398
AN:
39222
South Asian (SAS)
AF:
0.629
AC:
53433
AN:
84950
European-Finnish (FIN)
AF:
0.525
AC:
27306
AN:
51984
Middle Eastern (MID)
AF:
0.649
AC:
3680
AN:
5674
European-Non Finnish (NFE)
AF:
0.535
AC:
591373
AN:
1105520
Other (OTH)
AF:
0.550
AC:
32983
AN:
59932
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
19729
39458
59188
78917
98646
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16880
33760
50640
67520
84400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.493
AC:
74994
AN:
152072
Hom.:
20148
Cov.:
32
AF XY:
0.501
AC XY:
37251
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.283
AC:
11735
AN:
41496
American (AMR)
AF:
0.646
AC:
9880
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.643
AC:
2230
AN:
3468
East Asian (EAS)
AF:
0.705
AC:
3623
AN:
5142
South Asian (SAS)
AF:
0.654
AC:
3149
AN:
4816
European-Finnish (FIN)
AF:
0.537
AC:
5684
AN:
10584
Middle Eastern (MID)
AF:
0.667
AC:
196
AN:
294
European-Non Finnish (NFE)
AF:
0.543
AC:
36871
AN:
67956
Other (OTH)
AF:
0.538
AC:
1135
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1844
3687
5531
7374
9218
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.513
Hom.:
29005
Bravo
AF:
0.491
Asia WGS
AF:
0.640
AC:
2226
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

von Willebrand disease type 2 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

von Willebrand disease type 3 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

von Willebrand disease type 1 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.9
DANN
Benign
0.59
PhyloP100
-0.42
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs216293; hg19: chr12-6153659; API